NCT04086719View on ClinicalTrials.gov

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions
Healthy Male Volunteers
Interventions
DRUG

BMS-986165

Oral administration of tablet BMS- 986165

DRUG

Pyrimethamine

Oral administration of Pyrimethamine in combination with BMS-986185

Trial Locations (1)

84124

PRA Health Sciences - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY